Moody Aldrich Partners LLC Axsome Therapeutics, Inc. Transaction History
Moody Aldrich Partners LLC
- $460 Million
- Q2 2025
A detailed history of Moody Aldrich Partners LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 61,410 shares of AXSM stock, worth $6.46 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
61,410
Previous 62,339
1.49%
Holding current value
$6.46 Million
Previous $7.27 Million
11.83%
% of portfolio
1.39%
Previous 1.71%
Shares
25 transactions
Others Institutions Holding AXSM
# of Institutions
400Shares Held
37.3MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$347 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$178 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$160 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$120 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.51B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...